PHARMAMAR HA OPTADO POR LA RETIRADA DE LA SOLICITUD DE AUTORIZACIÓN DE COMERCIALIZACIÓN DE APLIDIN ( PLITIDEPSIN ) ... WITHDRAWAL OF APPLICATIÓN FOR THE MARKETING AUTHORISATION OF APLIDIN ( PLITIDEPSIN ) JULY 23 , 2025 .
... Belgium-based TiGenix raised $36 million on the sale of 2.3 million ADSs at a 14% discount to the converted price of the Euronext-listed shares. Its first day drop of 24.5% was the worst first-day performance of the year.